TY - JOUR
T1 - C-reactive protein and copeptin
T2 - Prognostic predictors in chronic obstructive pulmonary disease exacerbations
AU - Antonescu-Turcu, Andreea L.
AU - Tomic, Rade
PY - 2009/3/1
Y1 - 2009/3/1
N2 - Purpose of review Acute exacerbation of chronic obstructive pulmonary disease (COPD) is a natural event in the course of COPD and remains a major cause of morbidity and mortality associated with this disease. Clinical criteria that define an acute exacerbation are subjective and open for debate. Identifying biomarkers that would be easily measured and followed in patients with acute exacerbation of COPD seems to be highly attractive. The aim of this review is to assess the role of biomarkers, C-reactive protein (CRP) and copeptin, as prognostic predictors in COPD exacerbations. Recent findings Many pulmonary biomarkers have been extensively studied in the recent years. CRP and copeptin have gained particular interest. Recent data suggest that CRP is elevated during an acute exacerbation of COPD but CRP alone is neither sensitive nor specific in predicting clinical severity or outcome. Copeptin increases during acute exacerbation of COPD and may correlate with disease severity. Summary Further studies are needed to determine the role of CRP and copeptin as biomarkers that aid in diagnosis and clinical outcome in acute exacerbation of COPD.
AB - Purpose of review Acute exacerbation of chronic obstructive pulmonary disease (COPD) is a natural event in the course of COPD and remains a major cause of morbidity and mortality associated with this disease. Clinical criteria that define an acute exacerbation are subjective and open for debate. Identifying biomarkers that would be easily measured and followed in patients with acute exacerbation of COPD seems to be highly attractive. The aim of this review is to assess the role of biomarkers, C-reactive protein (CRP) and copeptin, as prognostic predictors in COPD exacerbations. Recent findings Many pulmonary biomarkers have been extensively studied in the recent years. CRP and copeptin have gained particular interest. Recent data suggest that CRP is elevated during an acute exacerbation of COPD but CRP alone is neither sensitive nor specific in predicting clinical severity or outcome. Copeptin increases during acute exacerbation of COPD and may correlate with disease severity. Summary Further studies are needed to determine the role of CRP and copeptin as biomarkers that aid in diagnosis and clinical outcome in acute exacerbation of COPD.
KW - Acute exacerbation of chronic obstructive pulmonary disease
KW - C-reactive protein
KW - Copeptin
KW - Systemic inflammation
UR - http://www.scopus.com/inward/record.url?scp=62349134599&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=62349134599&partnerID=8YFLogxK
U2 - 10.1097/MCP.0b013e3283218603
DO - 10.1097/MCP.0b013e3283218603
M3 - Review article
C2 - 19532026
AN - SCOPUS:62349134599
SN - 1070-5287
VL - 15
SP - 120
EP - 125
JO - Current Opinion in Pulmonary Medicine
JF - Current Opinion in Pulmonary Medicine
IS - 2
ER -